Previous 10 | Next 10 |
Data presented at the 2020 Winter Clinical Dermatology Conference Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the presentation of clinical utility data for i...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
The 180-day lockup period for Castle Biosciences Inc . ( CSTL ) ends on January 21, 2020 . When the lockup ends, company's pre-IPO shareholders and insiders may choose to sell more than 10.4 million shares of CSTL in the secondary market. The number of currently-restricted shares dwarfs the ...
Thinly traded Castle Biosciences ( CSTL +1.7% ) is up, albeit on a modest 19K shares, on the heels of its Q4 update . Highlights: More news on: Castle Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Castle Biosciences, Inc. (Nasdaq: CSTL) today announced that results from a study designed to perform a systematic review of the literature and establish the level of evidence for the Company’s DecisionDx®-Melanoma gene expression profile test were published in the December 2019 i...
Gainers: Iterum Therapeutics (NASDAQ: ITRM ) +121% . More news on: Iterum Therapeutics plc, Pintec Technology Holdings Limited, PDS Biotechnology Corporation, Stocks on the move, Read more ...
Castle Biosciences (NASDAQ: CSTL ) soars 26% after Canaccord Genuity analyst Mark Massaro boosts his price target and describes the company as "an underappreciated pure-play leader in melanoma diagnostics that is just getting started." More news on: Castle Biosciences, Inc...
Castle Biosciences, Inc. (Nasdaq: CSTL) today announced that the Company was recently added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to the market open on Monday, December 23, 2019. The NASDAQ Biotechnology Index is designed to track the performance of a set of sec...
Castle Biosciences, Inc. (Nasdaq: CSTL) today announced that its presentation at the Evercore ISI Second Annual HealthCONx Conference is now scheduled for 11:45 a.m. Eastern time on Thursday, December 5, 2019, in Boston. A live audio webcast of the company’s presentation will be av...
Data was presented during the 16 th International Congress of the Society for Melanoma Research Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the presentation...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Canaccord Genuity 44 th Annual Growth Conference on Tuesday, Aug. 13, 2024, at ...
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...